NOSTRUM BIODISCOVERY S.L. is a spin-off of the Barcelona Supercomputing Center (BSC) and the Institute for Research in Biomedicine (IRB) in Spain, devoted to the development and exploitation of state-of-the-art AI-driven computational (bio)chemistry and simulation tools for the design of next-generation therapies and biotechnology products.

Both the Nucleic Acids & Protein Engineering depts of Nostrum Biodiscovery use and develop proprietary computational tools, aiming to streamline Nucleic Acid & Protein Engineering research.

Nostrum provides services and cutting-edge in silico technologies to biopharmaceutical and biotechnology companies, CROs, and Academia in order to perform rational Drug Discovery, Protein Engineering Engineering, and Nucleic Acids. Nostrum also actively seeks collaborative frameworks and potential co-development projects.

With our proprietary technologies, we can reduce costs and time by more than 50% compared with traditional methods.